|
Jun 18
|
Britain’s biggest stock broker poised to approve £5.4bn Abu Dhabi-backed takeover
|
|
Jun 18
|
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month
|
|
Jun 18
|
Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a Bet
|
|
Jun 18
|
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
|
|
Jun 17
|
Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs
|
|
Jun 17
|
Could Structure Therapeutics Become the Next Novo Nordisk?
|
|
Jun 17
|
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
|
|
Jun 15
|
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
|
|
Jun 14
|
Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
|
|
Jun 14
|
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
|
|
Jun 14
|
Eli Lilly unveils new manufacturing plant for GLP-1 pens
|
|
Jun 14
|
IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
|
|
Jun 14
|
Few IBD 50 Stocks In Buy Zones; Netflix Is One
|
|
Jun 14
|
Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
|
|
Jun 14
|
Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
|
|
Jun 14
|
Earnings Growth & Price Strength Make Novo Nordisk (NVO) a Stock to Watch
|
|
Apr 25
|
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
|
|
Apr 25
|
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
|
|
Apr 24
|
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
|
|
Apr 24
|
Sector Update: Health Care Stocks Slipping Late Afternoon
|